PEPPI Study: Identification of Women at Risk for Placental Dysfunction
Recruiting
Observational Study
Pre-Eclampsia
Intrauterine Growth Restriction
Polycystic Ovary Syndrome
Iron-deficiency
Cardiovascular Diseases
Hypertensive Disorder of Pregnancy
Proteinuria in Pregnancy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- Oulu University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population. Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Mothers
Inclusion Criteria for PEPPI-study
* Pregnant (first trimester)
* Understands Finnish
* ≥18 years
* Signed informed consent
Exclusion Criteria
* Multiple pregnancy
* Miscarriage/termination of the index pregnancy
* No first trimester blood sampling
Inclusion Criteria for FERPPI-study
*…
Contacts